Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (461-470 of 517) with videos related to

Pageof 52
Sort By:
JAMA|March 23, 2006
Remissions in maternal depression and child psychopathology: a STAR*D-child reportMyrna M Weissman, Daniel J Pilowsky, Priya J Wickramaratne, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study designA John Rush, M Lynn Crismon, T Michael Kashner, et al.
Blood|March 16, 2007
A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemiaTing-lei Gu, Thomas Mercher, Jeffrey W Tyner, et al.
Biological Psychiatry|September 6, 2005
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic studyA John Rush, Harold A Sackeim, Lauren B Marangell, et al.
The American Journal of Psychiatry|May 4, 2011
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized studyA John Rush, Madhukar H Trivedi, Jonathan W Stewart, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 16, 2021
Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settingsArjun P Athreya, Tanja Brückl, Elisabeth B Binder, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2019
The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatientsJoseph M Trombello, Michael O Killian, Bruce D Grannemann, et al.
Brain, Behavior, and Immunity|February 8, 2022
Metabolomic and inflammatory signatures of symptom dimensions in major depressionChristopher R Brydges, Sudeepa Bhattacharyya, Siamak Mahmoudian Dehkordi, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of maniaTrisha Suppes, A John Rush, Ellen B Dennehy, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 7, 2017
Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statementSeetal Dodd, Philip B Mitchell, Michael Bauer, et al.
Pageof 52

Showing results (461-470 of 517) with videos related to

Sort By:
Pageof 52
JAMA|March 23, 2006
Remissions in maternal depression and child psychopathology: a STAR*D-child reportMyrna M Weissman, Daniel J Pilowsky, Priya J Wickramaratne, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study designA John Rush, M Lynn Crismon, T Michael Kashner, et al.
Blood|March 16, 2007
A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemiaTing-lei Gu, Thomas Mercher, Jeffrey W Tyner, et al.
Biological Psychiatry|September 6, 2005
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic studyA John Rush, Harold A Sackeim, Lauren B Marangell, et al.
The American Journal of Psychiatry|May 4, 2011
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized studyA John Rush, Madhukar H Trivedi, Jonathan W Stewart, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 16, 2021
Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settingsArjun P Athreya, Tanja Brückl, Elisabeth B Binder, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2019
The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatientsJoseph M Trombello, Michael O Killian, Bruce D Grannemann, et al.
Brain, Behavior, and Immunity|February 8, 2022
Metabolomic and inflammatory signatures of symptom dimensions in major depressionChristopher R Brydges, Sudeepa Bhattacharyya, Siamak Mahmoudian Dehkordi, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of maniaTrisha Suppes, A John Rush, Ellen B Dennehy, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 7, 2017
Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statementSeetal Dodd, Philip B Mitchell, Michael Bauer, et al.
Pageof 52